A 2012 essay written by a Michigan Senate candidate is now the center of a breast cancer funding firestorm on national television.
Story Snapshot
- Fox News host Laura Ingraham resurfaced a 2012 essay by Michigan Senate candidate Abdul El-Sayed criticizing breast cancer research funding.
- El-Sayed’s essay called funding growth “disturbing” and tied breast cancer advocacy to “social power and privilege.”
- National Institutes of Health (NIH) Director Dr. Jay Bhattacharya reacted to the remarks on Ingraham’s show, calling them stunning.
- El-Sayed’s Republican opponent, Mike Rogers, has launched an ad campaign built around the old essay.
What El-Sayed Wrote Back in 2012
Abdul El-Sayed published an essay titled “The Pink Ribbon Lobby and Everyone Else” in the 2×2 Project back in 2012. In it, he called the growth of federal breast cancer research funding “disturbing” and argued it raised questions about “equity in health research allocation.” He wrote that advocacy groups had done “an incredible job” raising awareness, almost to a fault.
El-Sayed went further, suggesting that breast cancer’s outsized funding might reflect something other than pure medical need. He wrote that disease advocacy could be “a function of the social power and privilege of those most likely to get a disease.” That line, more than any other, has become the epicenter of the current backlash against him.
How Ingraham Turned an Old Essay Into a Cable News Moment
Laura Ingraham dedicated segments of her Fox News show to the resurfaced essay, telling viewers “this El-Sayed story keeps getting worse.” She brought NIH Director Dr. Jay Bhattacharya on air, who reportedly said he was stunned by the comments. The pairing of a sitting federal health official with a blunt cable news takedown gave the story extra weight beyond typical campaign sparring.
To be fair to El-Sayed, the essay did include a qualifier that often gets left out of the viral clips. He wrote plainly that breast cancer “isn’t an incredibly important disease, which it is” — before pivoting to say the “reallocation of public funds disproportionately to breast cancer is certainly not” warranted. That distinction matters. His complaint was about allocation across diseases, not a denial that breast cancer deserves serious research dollars.
Why the Line Still Lands as Tone-Deaf
Even with that nuance, the phrasing was always going to be a political liability. Breast cancer touches nearly every American family, and framing its funding success as a byproduct of “privilege” reads as dismissive to survivors and their loved ones. Common sense says you don’t need a public health degree to know that comparing cancer awareness to a “lobby” problem is a bad look on the campaign trail, regardless of the wonkish point underneath it.
Republican opponent Mike Rogers wasted no time turning the essay into a campaign ad, hammering El-Sayed’s past writing as evidence he is out of touch with everyday voters. Multiple conservative outlets, including Breitbart and Townhall, picked up the story within days of each other, giving it the kind of coordinated amplification that turns an old blog post into a defining campaign issue.
The Bigger Policy Debate Behind the Outrage
El-Sayed’s underlying point touches a real and long-running debate in public health circles. Researchers have documented that disease-specific advocacy, including breast cancer campaigns, reshaped how the National Institutes of Health distributes research money over the past several decades. Some academic studies have found that diseases with the most organized patient advocacy secured disproportionate funding increases compared to their actual health burden.
None of that scholarly debate excuses the way El-Sayed framed his argument in 2012. There’s a difference between raising a legitimate policy question about research funding formulas and suggesting that breast cancer patients benefit from unearned “privilege.” Voters are right to weigh both the substance and the tone when deciding whether a candidate’s old words reflect bad judgment or just clumsy writing.
What Comes Next in the Michigan Senate Race
El-Sayed has not offered a detailed public response to the resurfaced essay as of this writing, leaving Ingraham’s framing largely unanswered on the airwaves. That silence gives Rogers and conservative media an open lane to keep pressing the issue heading into the Michigan Senate race. Whether El-Sayed addresses it directly or lets the story fade will likely shape how much staying power this controversy has with voters.
For now, the essay stands as a cautionary tale about how yesterday’s academic musings can become tomorrow’s campaign liability, especially when the subject is as personal to voters as breast cancer.
Sources:
twitchy.com, yahoo.com, breitbart.com, foxnews.com
